Probiotics as Edible Vaccines

Sahil Verma,Uttam C. Banerjee

DOI: https://doi.org/10.1007/978-981-33-6236-9_14

2021-01-01

Abstract:An era where an immunization has become a mandate to safeguard the biological system from the pathogens, vaccines have proven out to be the boon. Vaccines are an embodiment of microorganisms in an enfeeble state, just adequate to trigger the host immune system. Administered orally or through parenteral routes (IM: Intramuscular, SC: Subcutaneous, ID: Intradermal), vaccines evoke a defensive response of the biological system, i.e. the active type immunity. However, discomfort and anaphylaxis reactions associated with parenteral route are shortcomings. Thus, to bestow a better patient compliance, oral vaccines play a very crucial rule. An effortless administration of oral vaccines from paediatric to geriatric age groups with an increased patient compliance has initiated a league among the researchers to unearth potentials of oral vaccines. There are attempts of plant-based vaccines whereby the potential of plants as antigenic/epitope protein bio-factories are harnessed. The plant associated post-translational modification problems halt to leverage the clinical potential. The potential of probiotics to get adapted to gene manipulations as well as their human gut relations renders them suitable oral vaccines. Probiotics being in association with the gut microbiota may serve as immunomodulators by eliciting an immune response. The gut-associated immune cells rise to the bait during epitope encounter. The cellular immune response gets provoked and triggers the humoral immune response by a series of regulatory pathways to generate specific antibodies. An upcoming era is to fully leverage the potential of probiotics as successful therapeutic agents, though a far flung exploration needs to be unveiled for various research impediments in rendering the probiotics as antigenic/epitope bio-factories.